Biotech giants Genentech and Sanofi are set to lay off hundreds of ... a decade to wind down production at its South San ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

A year and a half after Sanofi swooped in on Johnson & Johnson’s dismantled vaccines unit to pick up an E. coli candidate, the asset has failed its phase 3 trial. A scheduled review by the study ...

Sanofi is to take on Boehringer Ingelheim's ... particular attention to social matters" for existing workforces and locations, including skills and 'sensitivities' around jobs.